Balancing Quantity and Quality in Drug Discovery
Posted in Archive
| Tagged ADME / Tox, AI / data analytics / healthtech / informatics, Biochemistry, Biomarkers, Business, Chemical engineering, Chemistry, Clinical trials, Computational chemistry, Drug development, Drug discovery, Drug repositioning, Drug targets, Enabling technologies, Genetics / genomes, Genomics, High throughput screening, In Silico Biology, Lead discovery, Microbiology, Pharmacology, Preclinical, Protein chemistry / Proteomics, Regulatory, RNA, Screening, Sequencing, System biology, Target validation, Toxicology
